Published in Dig Dis Sci on October 13, 2007
Mass Screening for the Early Detection of Patients With Celiac Disease. | NCT05186038
The economics of coeliac disease: a population-based study. Aliment Pharmacol Ther (2010) 1.27
Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLoS One (2012) 1.04
Screening for celiac disease in average-risk and high-risk populations. Therap Adv Gastroenterol (2012) 0.97
Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.79
Implementation of National Institute for Health and Care Excellence (NICE) guidance to measure IgA with all coeliac screens: Can an affordable solution be devised? Clin Exp Immunol (2017) 0.75
Coeliac disease. Lancet (2003) 4.47
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology (2005) 3.33
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA (1976) 2.55
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49
Diagnosis of celiac sprue. Gastroenterology (1998) 2.11
What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology (2005) 1.89
Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults. Dig Dis Sci (1996) 1.71
Selective IgA deficiency in blood donors. Vox Sang (1975) 1.63
Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest (2004) 1.61
Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg (1995) 1.53
The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet (2006) 1.52
Celiac disease. Evid Rep Technol Assess (Summ) (2004) 1.28
Complications of upper GI endoscopy. Gastrointest Endosc (2002) 1.24
Screening of blood donors for IgA deficiency: a study of the donor population of south-west England. J Clin Pathol (1977) 1.22
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem (2004) 1.17
Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis. Clin Vaccine Immunol (2006) 1.10
Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease? Eur J Gastroenterol Hepatol (2004) 1.03
Complications of upper gastrointestinal endoscopy. Gastrointest Endosc Clin N Am (1996) 0.99
Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther (2005) 0.98
Selective IgA deficiency in blood donors. Am J Clin Pathol (1983) 0.97
Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2006) 0.97
Celiac disease diagnosis in misdiagnosed children. Pediatr Res (2000) 0.94
Prevalence of selective IgA deficiency in Spain: more than we thought. Blood (1997) 0.91
IgA deficiency in Czech healthy individuals and selected patient groups. Int Arch Allergy Immunol (2000) 0.86
Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am J Gastroenterol (2006) 0.83
Complications of upper gastrointestinal endoscopy and their management. Gastrointest Endosc Clin N Am (1994) 0.82
This month at the NIH: Final statement of NIH Consensus Conference on celiac disease. Gastroenterology (2005) 0.78
Biopsy is the gold standard of diagnosis of celiac sprue. Gastroenterology (1999) 0.78
Selective serum IgA deficiency in Icelanders. Frequency, family studies and Ig levels. Acta Med Scand (1982) 0.77
Frequency of IgA deficiency in blood donors and Rh negative women in Iceland. Acta Pathol Microbiol Scand C (1977) 0.76
HLA and IgA deficiency in blood donors. Hum Immunol (1986) 0.76
Coeliac disease. Lancet (2003) 0.76
[Frequency of selective IgA deficiency in Basque Country]. Med Clin (Barc) (2000) 0.75
Evaluating evidence from a decision analysis. J Am Board Fam Pract (1999) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med (2002) 3.77
Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke (2004) 2.86
Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension (2009) 2.37
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. Arch Intern Med (2010) 2.08
Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. Clin J Am Soc Nephrol (2007) 1.88
Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke (2003) 1.82
FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol (2005) 1.52
Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs). Evid Rep Technol Assess (Full Rep) (2007) 1.42
Changing physician knowledge, attitudes, and beliefs about migraine: evaluation of a new educational intervention. Headache (2006) 1.38
Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation. Stroke (2010) 1.33
Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective. J R Soc Interface (2011) 1.20
Effects of race and poverty on the process and outcome of inpatient rehabilitation services among stroke patients. Stroke (2003) 1.18
Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors. Genet Med (2007) 1.17
Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials (2009) 1.13
A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes (2004) 1.09
Relationship between nephrologist care and progression of chronic kidney disease. N C Med J (2007) 1.08
Alzheimer disease: operating characteristics of PET--a meta-analysis. Radiology (2004) 1.01
Headache management program improves outcome for chronic headache. Headache (2003) 0.99
Management of uterine leiomyomata: what do we really know? Obstet Gynecol (2002) 0.98
Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. JAMA (2006) 0.98
Simulating the impact of long-term care policy on family eldercare hours. Health Serv Res (2013) 0.95
Immunization and MS: a summary of published evidence and recommendations. Neurology (2002) 0.94
An economic analysis of external hip protector use in ambulatory nursing facility residents. Age Ageing (2003) 0.93
Opportunities for improving management of advanced chronic kidney disease. Am J Med Qual (2008) 0.92
The cost of visual impairment: purposes, perspectives, and guidance. Invest Ophthalmol Vis Sci (2010) 0.92
Chapter 11: challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators. J Gen Intern Med (2012) 0.90
An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS). J Thromb Thrombolysis (2010) 0.90
Burden of illness and satisfaction with care among patients with headache seen in a primary care setting. Headache (2005) 0.90
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 0.88
How strong is the relationship between functional status and quality of life among persons with stroke? J Rehabil Res Dev (2004) 0.87
Geographic variation and trends in carotid imaging among medicare beneficiaries, 2001 to 2006. Circ Cardiovasc Qual Outcomes (2010) 0.86
Health policy and outcome research in stroke. Stroke (2004) 0.86
Long-term clinical outcomes following coronary stenting. Arch Intern Med (2008) 0.85
Future living arrangements of Singaporeans with age-related dementia. Int Psychogeriatr (2012) 0.85
Methods guide for authors of systematic reviews of medical tests: a collaboration between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine. J Gen Intern Med (2012) 0.83
Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol (2004) 0.82
A clinical decision and economic analysis model of cancer pain management. Am J Manag Care (2003) 0.82
Chapter 5: assessing risk of bias as a domain of quality in medical test studies. J Gen Intern Med (2012) 0.82
Pharmacoeconomics of atrial fibrillation and stroke prevention. Am J Manag Care (2004) 0.81
Which approach to anticoagulation management is best? Illustration of an interactive mathematical model to support informed decision making. J Thromb Thrombolysis (2002) 0.81
Evidence-based practice center network and health technology assessment in the United States: bridging the cultural gap. Int J Technol Assess Health Care (2006) 0.81
Improving the process of developing technical reports for health care decision makers: using the theory of constraints in the evidence-based practice centers. Int J Technol Assess Health Care (2006) 0.81
Vitamin D levels and cognition in elderly adults in China. J Am Geriatr Soc (2014) 0.81
Recommendations for a clinical decision support for the management of individuals with chronic kidney disease. Clin J Am Soc Nephrol (2009) 0.81
Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT). J Eval Clin Pract (2002) 0.80
Chapter 7: grading a body of evidence on diagnostic tests. J Gen Intern Med (2012) 0.80
Effectiveness of assisted reproductive technology (ART). Evid Rep Technol Assess (Full Rep) (2008) 0.78
When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. Value Health (2003) 0.78
Medicare HMO penetration and mortality outcomes of ischemic stroke. Am J Manag Care (2006) 0.78
Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). BMC Cancer (2012) 0.78
Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization. Am J Cardiol (2005) 0.77
The chronic kidney disease model: a general purpose model of disease progression and treatment. BMC Med Inform Decis Mak (2011) 0.77
Utility of the advanced chronic kidney disease patient management tools: case studies. Am J Med Qual (2008) 0.77
Outcomes of second revascularization procedures after stent implantation. J Med Syst (2008) 0.76
To what extent should quality of care decisions be based on health outcomes data? Application to carotid endarterectomy. Stroke (2002) 0.76
Noninvasive imaging for coronary artery disease: a technology assessment for the Medicare Coverage Advisory Commission. Am Heart J (2007) 0.75
Is genetic testing for cytochrome P450 polymorphisms ready for implementation? Am Fam Physician (2007) 0.75
Usefulness of positron emission tomography in evaluating dementia. JAMA (2002) 0.75
Editorial comment--what can models teach us about stroke treatment? Sorting out the missing bits. Stroke (2004) 0.75
Making evidence-based practice improvement more than a comforting sentiment. Am J Med (2003) 0.75
Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment. Am J Alzheimers Dis Other Demen (2006) 0.75
How can modeling best contribute to the assessment of secondary stroke prevention strategies? Am J Med (2005) 0.75
Stakeholders' perspective on issues and challenges associated with care and treatment of aging-related cognitive impairment disorders in Singapore. Int Psychogeriatr (2011) 0.75
Use of data from nonrandomized trial designs in evidence reports: an application to treatment of pulmonary disease following spinal cord injury. J Rehabil Res Dev (2002) 0.75
Expert estimates of caregiver hours for older Singaporeans with dementia. Australas J Ageing (2012) 0.75
When to stress over triptans: a Markov analysis of cardiovascular risk in migraine treatment. Headache (2004) 0.75
Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis. J Cardiovasc Electrophysiol (2014) 0.75
Does distance modify the effect of self-testing in oral anticoagulation? Am J Manag Care (2016) 0.75
Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers. Am J Manag Care (2002) 0.75
Presence of and correction for interviewer error on an instrument assessing cognitive function of older adults. Geriatr Gerontol Int (2014) 0.75
Benefits of Population Segmentation Analysis for Developing Health Policy to Promote Patient-Centred Care. Ann Acad Med Singapore (2017) 0.75